Just checked out #SITC Member Brian Rini, MD from UCDavisMedSchool present the long-term results from the KEYNOTE-426 trial of immuno-based combination therapy for kidney cancer at #ASCO23 ASCO. Kidney Cancer #kidneycancer #CIM23 #WearWhite #Immune2Cancer #SITC 23
A remarkable meeting #sitcancer #SITC22
Deeply honoured to present our work on “antigen presentation machinery and tumor immune evasion in NSCLC”. #JITC
Waiting for #SITC23
#schalperlab #Yaleuniversity #YalePathRes #YaleMed #yalepathology #curecancer #Immunotherapy
Save the date for #SITC23 in San Diego on Nov 1-5! Can't wait to see you there next November! #immunotherapy #SurfinScientists
Great to see Mark Awad Dana-Farber Dr. Elizabeth A. Mittendorf Dana-Farber Dr. Jedd D. Wolchok Weill Cornell Medicine Meyer Cancer Center discuss recent developments in the field of neoadjuvant #immunotherapy at an #ASCO23 session mod. by Dr. Harriet M. Kluger Yale School of Medicine ( #SITC23 Committee Co-Chair)
Just caught a great session at #ASCO23 with Dr. Harriet M. Kluger from Yale School of Medicine and Siwen Hu-Lieskovan from Huntsman Cancer Institute, discussing their insights on resistance to #immunotherapy , biomarkers and combination therapies. Very insightful. #SITC23 #CIM23 #Immune2Cancer ASCO
BIG Thanks to Tianhong (Tina) Li, MD, PhD, from UC Davis Comprehensive Cancer Cent, for her efforts to recap #immuno -oncology research from #ASCO23 . Thanks for being a Society for Immunotherapy of Cancer Member. Access the daily coverage: ow.ly/PKRV50OEQzE
#CIM23 #SITC23 #immuno therapy #immune2cancer
Attention researchers! Showcase your innovative work amongst other #immunotherapy experts at #SITC23 . Submit your abstracts for the Regular and Young Investigator Awards now! Learn more: sitcancer.org/2023/abstracts… #cancerresearch #immunotherapy